St. Jude Medical (NYSE:STJ), which paused implantations of its Portico replacement heart valve last fall out of an abundance of caution, won the FDA’s approval to resume U.S. implants of the device in a clinical trial, the company said yesterday. Back in September 2014, St. Jude said CT scans turned up a potential problem with the Portico valves in […]
The post TAVI: St. Jude Medical can resume Portico trial appeared first on MassDevice.
from MassDevice http://ift.tt/1Fw2wjQ
Cap comentari:
Publica un comentari a l'entrada